Loading insider details...
Latest Form 4 (Jun 12, 2026): Grant/Award of 5,700 RCUS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Arcus Biosciences, Inc. (RCUS) | Grant/Award | 5,700 | n/a |
| May 15, 2026 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 31,250 | n/a |
| Jun 12, 2025 | Arcus Biosciences, Inc. (RCUS) | Grant/Award | 13,300 | n/a |
| May 19, 2025 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 25,000 | n/a |
| Jan 27, 2025 | Arcus Biosciences, Inc. (RCUS) | Grant/Award | 5,000 | n/a |
| Jun 7, 2024 | Arcus Biosciences, Inc. (RCUS) | Grant/Award | 8,400 | n/a |
| May 20, 2024 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 25,000 | n/a |
| Jun 17, 2023 | Arcus Biosciences, Inc. (RCUS) | Grant/Award | 6,800 | n/a |
| May 4, 2023 | Nurix Therapeutics, Inc. (NRIX) | Grant/Award | 25,000 | n/a |
| Jun 16, 2022 | Arcus Biosciences, Inc. (RCUS) | Grant/Award | 4,100 | n/a |